Therefore, in the present study, we selected four most widely studied polymorphisms in H19 (rs2839698, rs3024270, rs217727, and rs2735971), and evaluated their associations with RCC risk and prognosis in a two-stage case-control study comprising a total of 1,027 cases and 1,094 controls in Chinese population. Here, H19 is linked to renal cell carcinoma.